Linker length in podophyllotoxin–acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines

Author: Rothenborg-Jensen1 L.   Hansen4 H.F.   Wessel1 I.   Nitiss3 J.L.   Schmidt24 G.   Jensen2 P.B.   Sehested1 M.   Jensen12 L.H.  

Publisher: Cognizant Communication Corporation

ISSN: 1460-2148

Source: Anti-Cancer Drug Design, Vol.16, Iss.6, 2001-12, pp. : 305-315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content